urinary incontinence episodes

Related by string. * Urinary : urinary tract infections . urinary tract symptoms . recurrent urinary tract infections . acute urinary retention / Incontinence : urge urinary incontinence . urge incontinence . Heavy Incontinence Napkins Nappies . stress urinary incontinence / epi sode . epi sodes . EPISODES : Star Wars Episode III . Twilight Zone episode . Episode III Revenge * *

Related by context. Frequent words. (Click for all words.) 56 administered subcutaneously 56 #mg dose [001] 54 mg dose 54 subcutaneous injections 53 mcg kg 53 #mg dose [003] 53 Cmax 53 vasomotor symptoms 53 RLS symptoms 53 PEG Intron 53 plus methotrexate 53 pharmacokinetic profiles 52 montelukast 52 tipranavir 52 sustained virologic response 52 mg BID 52 mcg dose 52 cardiac toxicity 51 levetiracetam 51 eszopiclone 51 hypokalemia 51 mg QD 51 biodistribution 51 pharmacodynamic effects 51 RHUCIN 51 pharmacokinetic profile 51 esomeprazole 51 pramipexole 51 events SAEs 50 peg IFN 50 achieved statistical significance 50 Secondary endpoints 50 MAP# 50 plus dexamethasone 50 ROZEREM 50 events AEs 50 aliskiren 50 active comparator 49 fluticasone propionate 49 tamsulosin 49 pharmacokinetic properties 49 glatiramer acetate 49 lacosamide 49 systemic absorption 49 #mg/kg [002] 49 ARIMIDEX 49 lopinavir ritonavir 49 tiotropium 49 HCTZ 49 SEROQUEL XR 48 basal insulin 48 severe renal impairment 48 unfractionated heparin 48 dacarbazine 48 inhaled steroid 48 PEG INTRON 48 JANUVIA 47 Celecoxib 47 mg mL 47 cytotoxicity 47 sirolimus 47 ramelteon 47 antitumor activity 47 Topiramate 47 PegIntron 47 secondary endpoint 47 Secondary endpoints include 47 limiting toxicity 47 fluticasone 47 tolerability profile 47 budesonide 47 sensitivity specificity 47 glimepiride 47 Secondary endpoints included 47 valsartan 46 plus ribavirin 46 4mg 46 milligram dose 46 moxifloxacin 46 laboratory abnormalities 46 placebo 46 dronedarone 46 SAPHRIS 46 Lantus R 46 lamotrigine 46 ziprasidone 46 LDL lowering 46 systolic BP 46 Empatic 46 pravastatin 46 ONGLYZA 45 inactive placebo 45 febuxostat 45 immunogenicity 45 peginterferon alfa 2b 45 tacrolimus 45 treatment emergent adverse 45 leucovorin 45 Adverse events 45 bivalirudin 45 tolerability

Back to home page